Rapid Generation of Leukemogenic Chromosomal Translocations in Vivo Using CRISPR/Cas9

Overview

Journal Hemasphere

Publisher Wiley

Specialty Hematology

Date 2020 Nov 2

PMID 33134860

Citations 2

Authors

Yun Huang

Blerim Marovca

Susanne Dettwiler

Peter Karl Bode

Beat Bornhauser

Jean-Pierre Bourquin

Affiliations

Soon will be listed here.

Citing Articles

Modeling sarcoma relevant translocations using CRISPR-Cas9 in human embryonic stem derived mesenchymal precursors.

Vanoli F, Antonescu C Genes Chromosomes Cancer. 2023; 62(9):501-509.

PMID: 36965130 PMC: 10725040. DOI: 10.1002/gcc.23141.

BAF complexes drive proliferation and block myogenic differentiation in fusion-positive rhabdomyosarcoma.

Laubscher D, Gryder B, Sunkel B, Andresson T, Wachtel M, Das S Nat Commun. 2021; 12(1):6924.

PMID: 34836971 PMC: 8626462. DOI: 10.1038/s41467-021-27176-w.

References

Zhu S, Li W, Liu J, Chen C, Liao Q, Xu P . Genome-scale deletion screening of human long non-coding RNAs using a paired-guide RNA CRISPR-Cas9 library. Nat Biotechnol. 2016; 34(12):1279-1286. PMC: 5592164. DOI: 10.1038/nbt.3715. View

Blasco R, Karaca E, Ambrogio C, Cheong T, Karayol E, Minero V . Simple and rapid in vivo generation of chromosomal rearrangements using CRISPR/Cas9 technology. Cell Rep. 2014; 9(4):1219-27. DOI: 10.1016/j.celrep.2014.10.051. View

Duque-Afonso J, Smith K, Cleary M . Conditional Expression of E2A-HLF Induces B-Cell Precursor Death and Myeloproliferative-Like Disease in Knock-In Mice. PLoS One. 2015; 10(11):e0143216. PMC: 4654581. DOI: 10.1371/journal.pone.0143216. View

Nutt S, Heavey B, Rolink A, Busslinger M . Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature. 1999; 401(6753):556-62. DOI: 10.1038/44076. View

Andersson A, Ma J, Wang J, Chen X, Gedman A, Dang J . The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias. Nat Genet. 2015; 47(4):330-7. PMC: 4553269. DOI: 10.1038/ng.3230. View

Almosailleakh M, Schwaller J . Murine Models of Acute Myeloid Leukaemia. Int J Mol Sci. 2019; 20(2). PMC: 6358780. DOI: 10.3390/ijms20020453. View

Meyer C, Burmeister T, Groger D, Tsaur G, Fechina L, Renneville A . The MLL recombinome of acute leukemias in 2017. Leukemia. 2017; 32(2):273-284. PMC: 5808070. DOI: 10.1038/leu.2017.213. View

Jacoby E, Chien C, Fry T . Murine models of acute leukemia: important tools in current pediatric leukemia research. Front Oncol. 2014; 4:95. PMC: 4019869. DOI: 10.3389/fonc.2014.00095. View

Oldrini B, Curiel-Garcia A, Marques C, Matia V, Uluckan O, Grana-Castro O . Somatic genome editing with the RCAS-TVA-CRISPR-Cas9 system for precision tumor modeling. Nat Commun. 2018; 9(1):1466. PMC: 5899147. DOI: 10.1038/s41467-018-03731-w. View

10.

Forster A, Pannell R, Drynan L, McCormack M, Collins E, Daser A . Engineering de novo reciprocal chromosomal translocations associated with Mll to replicate primary events of human cancer. Cancer Cell. 2003; 3(5):449-58. DOI: 10.1016/s1535-6108(03)00106-5. View

11.

Fischer U, Forster M, Rinaldi A, Risch T, Sungalee S, Warnatz H . Genomics and drug profiling of fatal TCF3-HLF-positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options. Nat Genet. 2015; 47(9):1020-1029. PMC: 4603357. DOI: 10.1038/ng.3362. View

12.

Huang Y, Mouttet B, Warnatz H, Risch T, Rietmann F, Frommelt F . The Leukemogenic TCF3-HLF Complex Rewires Enhancers Driving Cellular Identity and Self-Renewal Conferring EP300 Vulnerability. Cancer Cell. 2019; 36(6):630-644.e9. DOI: 10.1016/j.ccell.2019.10.004. View

13.

Reimer J, Knoss S, Labuhn M, Charpentier E, Gohring G, Schlegelberger B . CRISPR-Cas9-induced t(11;19)/MLL-ENL translocations initiate leukemia in human hematopoietic progenitor cells . Haematologica. 2017; 102(9):1558-1566. PMC: 5685230. DOI: 10.3324/haematol.2017.164046. View

14.

Mertens F, Johansson B, Fioretos T, Mitelman F . The emerging complexity of gene fusions in cancer. Nat Rev Cancer. 2015; 15(6):371-81. DOI: 10.1038/nrc3947. View

15.

Brunet E, Jasin M . Induction of Chromosomal Translocations with CRISPR-Cas9 and Other Nucleases: Understanding the Repair Mechanisms That Give Rise to Translocations. Adv Exp Med Biol. 2018; 1044:15-25. PMC: 6333474. DOI: 10.1007/978-981-13-0593-1_2. View

16.

Platt R, Chen S, Zhou Y, Yim M, Swiech L, Kempton H . CRISPR-Cas9 knockin mice for genome editing and cancer modeling. Cell. 2014; 159(2):440-55. PMC: 4265475. DOI: 10.1016/j.cell.2014.09.014. View

17.

Sundara Rajan S, Li L, Kweh M, Kunkalla K, Amin A, Agarwal N . CRISPR genome editing of murine hematopoietic stem cells to create causes ALK lymphoma after transplantation. Blood Adv. 2019; 3(12):1788-1794. PMC: 6595257. DOI: 10.1182/bloodadvances.2018025247. View

18.

Maddalo D, Manchado E, Concepcion C, Bonetti C, Vidigal J, Han Y . In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system. Nature. 2014; 516(7531):423-7. PMC: 4270925. DOI: 10.1038/nature13902. View